The determination of trace amounts of zinc, cadmium, lead and copper in airborne particulate matter by anodic stripping voltammetry.

G. Colovos,G. S. Wilson,J. Moyers

DOI: https://doi.org/10.1016/S0003-2670(01)82477-6

IF: 6.911

1973-05-01

Analytica Chimica Acta

Abstract:

What problem does this paper attempt to address?

[Neurological background of Asperger's disorder and other pervasive developmental disorders].

M. Toichi

2007-03-01

Abstract:The core features of pervasive developmental disorder (PDD) are impairment in social interaction and restricted ranges of interest and activities with obsessive/compulsive traits. Clinical characteristics of PDD range across a variety of psychophysiological areas, from vigilance and autonomic arousal through attention to higher cognitive functions such as memory and language. The author reviewed hypotheses on the neurological background of PDD, which includes brainstem, cerebellum, prefrontal cortex, mirror neuron system, and amygdala and related circuit. Among them, the amygdala hypothesis appears to be most successful in explaining the core feature of PDD, i.e. social impairment. It is expected that advance in cognitive neuroscience on social behavior will clarify the link between neurological and clinical findings of Asperger's disorder.
A case of chronic retinal necrosis after tube shunt surgery for secondary glaucoma associated with cytomegalovirus corneal endotheliitis

Katsue Imamachi,Aika Tsutsui,Kaoru Manabe,Masaki Tanito

DOI: https://doi.org/10.1186/s12886-021-02019-w

2021-06-10

Abstract:Background: We report a case of chronic retinal necrosis (CRN) combined with cytomegalovirus (CMV) corneal endotheliitis. Case presentation: An 80-year old man was diagnosed with CRN that developed after tube shunt surgery with vitrectomy for secondary glaucoma associated with CMV corneal endotheliitis. After the use of oral valganciclovir and panretinal photocoagulation, the retinal lesion resolved rapidly and he has maintained visual acuity better than before the onset of CRN. Conclusions: Use of oral valganciclovir, prophylactic panretinal photocoagulation for the non- perfusion area and vitrectomy were effective in maintaining the visual acuity for the patient with CRN.
Insights on nitrogen balance in the Eastern Mediterranean Sea.

M. Krom

DOI: https://doi.org/10.1111/j.1462-2920.2010.02404.x

IF: 5.476

2011-04-01

Environmental Microbiology

Abstract:
Suspected Retinal Toxicity After Multiple Intravitreal Ganciclovir Injections in a Patient of CMV Retinitis

Rohan Kapoor,SriniVas Sadda,Mudit Tyagi

DOI: https://doi.org/10.1080/09273948.2024.2316754

2024-02-28

Ocular Immunology and Inflammation

Abstract:Purpose Intravitreal Ganciclovir has been one of the treatments of choice for cytomegalovirus (CMV) retinitis and has been used extensively for its treatment since 1987. It has not been shown to have any major adverse effects. There are no reports on any retinal toxicity even after multiple, repeated injections. Herein, we report a rare case of retinal toxicity after multiple intravitreal injections in a patient of CMV retinitis.

ophthalmology
Clinical Evaluation of Intravitreal Injection of Ganciclovir in Refractory Corneal Endotheliitis

Ting Yu,Rong-Mei Peng,Ge-Ge Xiao,Li-Na Feng,Jing Hong

DOI: https://doi.org/10.1080/09273948.2019.1573261

Abstract:Purpose: To evaluate the efficacy and safety of intravitreal ganciclovir (GCV) injection in refractory endotheliitis.Methods: Retrospectively recruited 25 eyes with endotheliitis, proved by clinical manifestations, positive PCR for viral DNA and responded poor to topical and systemic antiviral medications. All patients received additional continued intravitreal GCV injections.Results: Cytomegalovirus (CMV), varicella zoster virus (VZV), and herpes simplex virus (HSV) DNA were detected in 64.0%, 28.0%, and 8.0% of the eyes, respectively. Within 2 weeks after the last injection, 16/25 eyes recovered corneal clarity; active keratic precipitates (KPs) were eliminated in 21/25 eyes; intraocular pressure (IOP) was controlled in 12/15 eyes with elevated IOP on study entry. Best-corrected visual acuity increased at the last follow-up (p = 0.016). Clinical recurrence occurred in three patients. No complications were detected.Conclusions: CMV endotheliitis was the main type of refractory endotheliitis. Despite its invasive nature, intravitreal GCV injection appears to be an effective method for refractory endotheliitis.
An Unusual Cytomegalovirus Ocular Manifestation in a Non-HIV Patient

Emily Ng Ming Choo,Othmaliza Othman,Amelia Lay Suan Lim

DOI: https://doi.org/10.7759/cureus.21947

2022-02-05

Cureus

Abstract:A 60-year-old Aboriginal man with underlying severe exfoliative dermatitis, treated with oral azathioprine and oral prednisolone, presented with left painful red eye for ten days. On initial presentation, left eye vision was poor at hand motion. There was corneal endotheliitis over the left eye with severe anterior chamber inflammation obscuring the fundus view. B-scan ultrasonography showed evidence of vitritis with a flat retina. An urgent aqueous tap for viral polymerase chain reaction (PCR) yielded positive cytomegalovirus (CMV) DNA results. As CMV infection commonly affects immunosuppressed individuals, his systemic immunosuppressants were withheld temporarily. He was successfully treated with combination intravenous ganciclovir, intravitreal ganciclovir 2mg/0.1ml, and topical ganciclovir 2%. His vision improved significantly from hand motion to 20/40. There was no reactivation of CMV infection post-treatment.
Cytomegalovirus and the eye

A Carmichael

DOI: https://doi.org/10.1038/eye.2011.327

Abstract:Following primary infection, cytomegalovirus (CMV) establishes latent infection in myeloid progenitor cells and intermittent viral reactivation from activated macrophages or dendritic cells, which is brought under control by strong virus-specific CD4+ T-cell and CD8+ T-cell responses. CMV retinitis characterized by spreading retinal necrosis due to viral cytopathic effect occurs in patients who have impaired T-cell function as a result of transplantation, AIDS, or immuno-suppressive treatment. The diagnosis of CMV retinitis can be confirmed by PCR amplification of viral DNA in aqueous. When administered intravenously, the antiviral drugs Ganciclovir and Foscarnet have modest penetration into the vitreous compared with direct intra-vitreal injection. In randomized trials of HIV-associated CMV retinitis, a Ganciclovir implant was consistently superior to intravenous Ganciclovir in preventing progression of retinitis. CMV is also implicated in two forms of anterior segment disease in immuno-competent adults, namely CMV anterior uveitis and CMV corneal endotheliitis.
Multiple intravitreal injections of ganciclovir for cytomegalovirus retinitis after stem-cell transplantation

Heng Miao,Yong Tao,Yan-rong Jiang,Xiao-xin Li

DOI: https://doi.org/10.1007/s00417-013-2368-6

2013-01-01

Abstract:Background Cytomegalovirus (CMV) infection is a major cause of morbidity and mortality in patients after hematopoietic stem cell transplantation (HSCT). Although much effort has been put into dealing with CMV retinitis secondary to acquired immunodeficiency syndrome (AIDS), the few reports which have been published have mainly focused on treatment of CMVR after HSCT. Methods This clinical interventional retrospective study included 14 patients (eight men; mean age 23.89 ± 12.09; 23 eyes) who suffered from CMV retinitis after stem-cell transplantation, in order to evaluate the efficacy and safety of multiple intravitreal injections of ganciclovir (IVG) for patients with CMV retinitis. All patients received 4 injections of IVG of 1 mg at 1 week intervals, and were followed up weekly for at least 2 months with measurement of best-corrected visual acuity (BCVA) and CMV levels in anterior aqueous humor with real-time polymerase chain reaction. Anterior aqueous humor was obtained before each injection. Results The levels of CMV in anterior aqueous humor showed significant decrease from (6.34 ± 15.78) × 10 5 copies/ml at baseline to (5.22 ± 12.15) × 10 3 copies/ml at 1 month ( P < 0.001, Mann–Whitney U test). CMV couldn’t be detected in 11 eyes (47.8 %) after two injections, and this rose to 18 eyes (78.3 %) at 1 month. The mean logMAR BCVA was 0.659 ± 0.572 at baseline and 0.680 ± 0.527 at 2 months, which suggested no significant improvement ( P = 0.736, Mann–Whitney U test) during the procedure. All patients experienced improved vitreous opacity and diminished area of the lesion under funduscopy after 4 injections of IVG. No severe complications developed. Conclusions Multiple IVG seemed to be beneficial for patients with CMV retinitis after stem-cell transplantation, in reducing CMV levels in aqueous humor. Further study to optimize the dose of ganciclovir is needed in order to achieve better treatment outcomes.
A case of CMV endotheliitis treated with intravitreal ganciclovir injection

Won Seok Choi,Joon Hee Cho,Ha Kyoung Kim,Hyun Soo Kim,Young Joo Shin

DOI: https://doi.org/10.3341/kjo.2013.27.2.130

Abstract:We report a case of CMV corneal endotheliitis that was treated with intravitreal ganciclovir injection. A 56-year-old man who has suffered from uveitis was referred to our clinic due to corneal endothelial abnormality. Slit lamp examination showed a localized sectoral corneal edema and linear keratic precipitates along the boundary of edema. In spite of treatment with oral steroid and acyclovir, the disease progressed and two new coin-like lesions were developed. After topical ganciclovir and intavitreal injection of ganciclovir, the corneal lesions disappeared.
Case report: CMV retinitis following local and systemic immunosuppression

Bryant A Menke,William Wagner,Helen Song,William Thomas,Natalia E Castillo Almeida,Christopher D Conrady,Steven Yeh

DOI: https://doi.org/10.3389/fopht.2024.1354104

2024-03-06

Abstract:We report the case of a 71-year-old man who presented 2 years following renal transplantation with diffuse, unilateral cytomegalovirus retinitis five weeks after receiving an intravitreal dexamethasone implant device for the management of central retinal vein occlusion. Examination of the left eye showed diffuse retinal hemorrhages, attenuated and tortuous retinal vessels, and superior retinal whitening. The patient was successfully treated with serial intravitreal foscarnet injections and oral valganciclovir with disease regression observed by 12 weeks after presentation. The patient's visual acuity and examination remained stable at 9-months follow-up.
Antiviral therapy for cytomegalovirus retinitis: A systematic review and meta-analysis

Ikhwanuliman Putera,Rina La Distia Nora,Arlin Chyntia Dewi,Ditta Shabrina Suhada,Carlos Cifuentes-González,William Rojas-Carabali,Gazal Patnaik,Germán Mejia-Salgado,Ratna Sitompul,Lukman Edwar,Made Susiyanti,Yulia Aziza,Jyotirmay Biswas,Vishali Gupta,Alejandra de-la-Torre,Rupesh Agrawal

DOI: https://doi.org/10.1016/j.survophthal.2024.11.004

IF: 6.197

2024-11-24

Survey of Ophthalmology

Abstract:Cytomegalovirus retinitis (CMVR) is a significant cause of blindness in patients with advanced acquired immunodeficiency syndrome (AIDS). There are no established guidelines for its treatment, resulting in varied antiviral approaches. We pooled data from 59 studies (4501 patients) to evaluate treatment variations and outcomes (CRD42022321088). Overall pooled estimates showed visual acuity improvement at 18 % (95 % CI: 7–41 %), inflammation resolution at 90 % (95 % CI: 81–95 %), retinal detachment at 11 % (95 % CI: 8–14 %), and recurrence at 19 % (95 % CI: 11–31 %). The main antiviral treatment approaches identified were: (1) intravenous antivirals alone in 33 studies, (2) intravitreal antivirals alone in 26 studies, (3) oral antivirals alone in 3 studies, and (4) a combination of systemic (oral or intravenous[IV]) and intravitreal antivirals in 7 studies, with varying schemes and durations. Ganciclovir was the predominant antiviral, with intravenous administration being the most reported (in 23 studies), followed by intravitreal administration (in 20 studies). While visual acuity improvement was comparable, inflammation resolution tended to be higher with intravitreal than with IV antivirals, though not statistically significant (88 %, 95 % CI: 69–96 % vs 75 %, 95 % CI: 35–94 %, p = 0.38). Retinitis progression rate for IV ganciclovir was lower than for those without ganciclovir. Inflammation recurrence was significantly lower in antiretroviral (ART)-treated compared to non-ART-treated HIV/AIDS patients (10 % (95 % CI: 4–20 %) vs 33 % (95 % CI: 19–50 %), p < 0.01). Neutropenia, particularly with ganciclovir, was the most reported adverse effect (up to 50 %).

ophthalmology
Cytomegalovirus anterior uveitis and occlusive retinal vasculitis without retinitis in a patient on immunomodulatory therapy

Lorenzo Fabozzi,Ilaria Testi,Laura De Benito-Llopis,Carlos Pavesio

DOI: https://doi.org/10.1186/s12348-023-00356-z

2023-08-04

Abstract:Purpose: To describe unusual clinical features and therapeutic management of a case of cytomegalovirus (CMV) ocular disease in a patient on immunomodulatory therapy. Setting/venue: Moorfields Eye Hospital NHS Foundation Trust, London, UK. Methods: Medical history, clinical findings, investigation results, and multimodal imaging were retrospectively collected. Results: A 61-year-old, South-East Asian man, developed CMV-related endotheliitis and occlusive retinal vasculitis, diagnosed by wide-angle fluorescein angiography. No retinitis was present on the fundus examination. Suspicion of CMV etiology was based on anterior segment findings, especially the presence of coin-shaped endothelial lesions. The diagnosis was confirmed by aqueous polymerase chain reaction (PCR) analysis which was positive for CMV DNA. The combined use of topical and systemic valganciclovir resulted in significant improvement of the picture. Conclusions: CMV can manifest in the eye as occlusive retinal vasculitis without the presence of typical retinitis.
Continuous High-Dose (6 mg) vs. Low-Dose (3 mg) Intravitreal Ganciclovir for Cytomegalovirus Retinitis After Haploidentical Hematopoietic Stem Cell Transplantation: A Randomized Controlled Study

Wei-Bin Chen,Ze Long,Jing Hou,Heng Miao,Ming-wei Zhao

DOI: https://doi.org/10.3389/fmed.2021.750760

IF: 3.9

2021-12-24

Frontiers in Medicine

Abstract:Purpose: To evaluate the safety and efficacy of continuous high-dose (6 mg) intravitreal ganciclovir injections (IVG) for cytomegalovirus (CMV) retinitis (CMVR) after haploidentical hematopoietic stem cell transplantation (Haplo-HSCT), and to explore factors that may influence the treatment procedure. Design: Prospective, randomized, single-blinded, positive-controlled, interventional, comparative study. Methods: A total of 22 patients with CMVR (32 eyes) were randomized to either high-dose group (IVG 6 mg weekly) or low-dose group (IVG 3 mg given twice weekly for 2 weeks as induction phase and weekly thereafter as maintenance phase). Patients who were recorded any positive CMV DNAemia or other active CMV diseases and needed systemic anti-CMV treatment during the study period were excluded. The vision outcome, variables of the treatment procedure, and incidence of complication and CMVR recurrence were analyzed and compared. Logistic regression was applied to determine the factors that may have an impact on the treatment process at baseline. Results: Compared to the low-dose group, the high-dose group resulted in a median of two less intravitreal injections (4 vs. 6 times, respectively, P = 0.016), while the rate of vision stability or improvement (81.2 vs. 87.5%), the incidence of complication (6.2 vs. 18.8%), and CMVR recurrence (12.5% vs. 6.2%) were similar (all P > 0.05). No drug-related toxicity was observed. Initial aqueous CMV-DNA load (OR: 6.872, 95% CI: 1.335–35.377, P = 0.021) and extension of lesion (OR: 0.942, 95% CI: 0.897 to .991, P = 0.020), but not dosing regimen ( P = 0.162), were predictors of the treatment duration. Conclusions: Continuous high-dose regimen was well tolerated and resulted in less intravitreal injections, with similar vision outcomes and safety profiles. The clinical course of CMVR after Haplo-HSCT was determined by its own nature at baseline and could not be modified by treatment protocols under consistent immune background.

medicine, general & internal
An Uncommon Concurrence of Cytomegalovirus Retinitis and Corneal Endotheliitis in an Immunocompromised HIV-Negative Patient

Tzu-En Kao,Yo-Chen Chang,Po-Yen Lee

DOI: https://doi.org/10.1080/09273948.2019.1695859

2021-04-03

Abstract:Purpose: To describe a case of Cytomegalovirus (CMV) retinitis in both eyes complicated with unilateral corneal endotheliitis in an iatrogenic immunocompromised patient.Methods: A retrospective case report.Result: A 58-year-old male, on long-term immunosuppressive treatment for chronic glomerulonephritis and nephrotic syndrome. Ocular examination revealed bilateral vitritis and necrotizing retinitis and concurrent corneal endotheliitis with ocular hypertension in his left eye. The PCR result showed positivity for CMV infection by diagnostic aqueous aspiration. Vitritis/retinitis in both eyes resolved gradually after systemic valganciclovir use, and the endotheliitis in the left eye regressed after topical antiviral treatment. There was no recurrence of retinitis/endotheliitis with a maintenance dose of oral valganciclovir. Unfortunately, tractional macular hole developed in the left eye and complicated the visual outcome.Conclusion: CMV retinitis may occur in HIV-negative immunocompromised individuals, but CMV endotheliitis generally appears in the immunocompetent. It is a rare combination of CMV retinitis and endotheliitis in this patient.
Effectiveness of Topical Ganciclovir 2% Monotherapy Versus Combined Steroid Therapy in Cytomegalovirus Endotheliitis

Yu-Wei Kuo,En-Che Chang,Chia-Yi Lee,Shwu-Huey Lee,I-Chia Liang,Yi-Chun Chen,Yu-Chih Hou

DOI: https://doi.org/10.3390/jcm11195811

2022-09-30

Abstract:We aimed to report the clinical manifestations of cytomegalovirus (CMV) corneal endotheliitis and the results of long-term treatment with topical ganciclovir 2% with and without steroids. This retrospective, interventional study included 15 eyes of 13 patients diagnosed with CMV corneal endotheliitis by positive CMV DNA and treated with long-term topical ganciclovir 2% eye drops at a tertiary referral center and the median follow-up period was 17 months. Ocular manifestations included keratic precipitates (KPs) (100%), elevated IOP (93.3%), iritis (60%), corneal edema (60%), and moth-eaten iris atrophy (60%). After long-term treatment, corneal edema, iritis, and KPs significantly decreased (effect size: 72%, 76% and 70%, respectively; p = 0.024, p = 0.006 and p < 0.001, respectively). Both the logMAR acuity and IOP significantly improved (median logMAR was 0.52 before treatment and 0.22 after treatment; median IOP was 42 mmHg before treatment and 12 mmHg after treatment; p = 0.001 and p < 0.001, respectively). The ECD was maintained (effect size: 80%), and the percentage of hexagonal cell ratio of endothelial cells significantly improved after treatment (effect size: 82%; p = 0.035). Fewer anti-glaucoma medications were used in the non-steroid group (effect size: 79%; p = 0.034). Long-term maintenance treatment with topical ganciclovir 2% monotherapy not only provides effective therapy and reduces recurrence, but also decreases the high IOP related to the combination of steroids used.
Cytokines pattern after surgical radiofrequency ablation of liver colorectal metastases.

S. Evrard,C. Ménétrier-Caux,C. Biota,V. Neaud,S. Mathoulin-Pélissier,J. Blay,J. Rosenbaum

DOI: https://doi.org/10.1016/S0399-8320(07)89344-4

2007-02-01

Gastroentérologie Clinique et Biologique

Abstract:
Measuring adolescent care in general practice--successes, problems, and pitfalls.

L. Jacobson,C. Donovan,D. Churchill

2001-05-01

Abstract:
Severe Occlusive Retinal Vasculitis in an Immunocompetent Patient with Chronic CMV Anterior Uveitis

Marko Chi-Wei Tien,Alexander J Kaplan

DOI: https://doi.org/10.1080/09273948.2024.2389460

2024-08-08

Abstract:Purpose: We report a unique case of non-necrotizing occlusive retinal vasculitis presenting two years following chronic hypertensive uveitis. Methods: Case Report. Results: A 32-year-old Iraqi woman with a history of Posner-Schlossman Syndrome diagnosed 10 years prior presented with blurred vision and redness in her left eye. Examination demonstrated ocular hypertension, keratic precipitates, and inflammatory cells in the anterior chamber. Quantitative real-time PCR confirmed the presence of cytomegalovirus in the aqueous humor, and dilated posterior segment examination was negative for any signs of intraocular inflammation, retinitis, or vasculitis. Her uveitis workup was otherwise negative, and she was treated with valganciclovir for 6 months. Two years after her initial presentation, she was noted to have a new vitreous hemorrhage in the left eye. Fluorescein angiography demonstrated an occlusive retinal vasculitis with extensive neovascularization without retinitis. Quantitative real-time PCR again demonstrated the presence of cytomegalovirus in the anterior chamber. Her uveitis workup was repeated, which has now returned positive for HLA-B51. She otherwise did not demonstrate any systemic signs of Behcet's Disease. She was restarted on valganciclovir and oral prednisone and referred to rheumatology for consideration of adalimumab initiation. Thus far she has responded very well to treatment. Conclusion: This case highlights the importance of serial posterior segment examinations and HLA-B51 testing in individuals with cytomegalovirus anterior uveitis.
Prenatal diagnosis of an aberrant right subclavian artery: four vessels arising from the aortic arch?

E. Quarello,J. S. Carvalho

DOI: https://doi.org/10.1002/uog.6335

2009-04-01

Ultrasound in Obstetrics and Gynecology

Abstract:We read with interest the article by Chaoui et al.1 about the aortic arch with four vessels due to an aberrant right subclavian artery (ARSA). The authors previously reported how to diagnose or rule out the anomalous origin of the subclavian artery in the fetus using transverse views2 which allow ARSA to be demonstrated as early as in the first-trimester scan. In their recent article1, the authors report that ARSA can also be identified in a longitudinal view of the aortic arch when four vessels arise from it. The ARSA usually originates as the last branch of the aortic arch, below its junction with the ductus arteriosus, and courses behind the trachea and esophagus towards the right clavicle and shoulder. Depending on the exact level as well as from which side of the descending aorta the ARSA originates, this anomalous origin may be overlooked if only a longitudinal view of the aortic arch is used. We present a case in which this view was certainly not the best plane to rule out the presence of an ARSA. This is illustrated in the accompanying threedimensional images, in which the ARSA can be seen to originate anteriorly from the descending aorta, far away from the junction between the aortic arch and the ductus arteriosus, and to course towards the right side (Figures 1 and 2). Images were obtained transabdominally using a 4–8-MHz probe (Voluson 730 Expert system, GE Medical Systems, Zipf, Austria). Theoretically, an aortic arch with four vessels may be found in several situations, such as a left arch with an
Topical ganciclovir treatment in patients with cytomegalovirus endotheliitis receiving penetrating keratoplasty

Chien-Chia Su,I-Jong Wang,Wei-Li Chen,Chang-Pin Lin,Brian His,Fung-Rong Hu

DOI: https://doi.org/10.1111/j.1442-9071.2012.02888.x

Abstract:Background: To report seven cases diagnosed as cytomegalovirus endotheliitis and treated with topical 2% ganciclovir following penetrating keratoplasty. Design: A retrospectively comparative case series. Participants: A retrospective interventional case series, including seven eyes of seven patients with cytomegalovirus endotheliitis after penetrating keratoplasty. Methods: Clinical and immunological characteristics were studied in seven penetrating keratoplasty cases with positive quantitative polymerase chain reaction results for cytomegalovirus DNA from aqueous taps and treated with topical 2% ganciclovir. Main outcome measures: Clinical features and responses to topical 2% ganciclovir. Results: Seven immunocompetent patients experienced acute anterior inflammation with graft oedema and pigmented keratic precipitates after penetrating keratoplasty. Their immunological profiles showed immunoglobulin G cytomegalovirus (+) and immunoglobulin M cytomegalovirus (-) in all cases. Topical 2% ganciclovir was prescribed every 2 to 3 h daily as induction therapy and every 4 h as long-term maintenance therapy. All cases had undetectable cytomegalovirus DNA after follow-up aqueous taps. Topical 2% ganciclovir preserved endothelium of cytomegalovirus-infected grafts at early stage and also provided a steady anticytomegalovirus environment for further regrafting in failed grafts at late stage. Acute inflammation reactivated in two cases and was suppressible by steroid under topical ganciclovir. No delayed re-epithelialization and any toxicity were observed. To date, no case treated in this way had displayed cytomegalovirus recurrence. Conclusions: Continuous topical 2% ganciclovir and a topical steroid adjusted by anterior inflammation are suggested after penetrating keratoplasty in all cases with cytomegalovirus endotheliitis to prevent cytomegalovirus recurrence.

The determination of trace amounts of zinc, cadmium, lead and copper in airborne particulate matter by anodic stripping voltammetry.

[Neurological background of Asperger's disorder and other pervasive developmental disorders].

A case of chronic retinal necrosis after tube shunt surgery for secondary glaucoma associated with cytomegalovirus corneal endotheliitis

Insights on nitrogen balance in the Eastern Mediterranean Sea.

Suspected Retinal Toxicity After Multiple Intravitreal Ganciclovir Injections in a Patient of CMV Retinitis

Clinical Evaluation of Intravitreal Injection of Ganciclovir in Refractory Corneal Endotheliitis

An Unusual Cytomegalovirus Ocular Manifestation in a Non-HIV Patient

Cytomegalovirus and the eye

Multiple intravitreal injections of ganciclovir for cytomegalovirus retinitis after stem-cell transplantation

A case of CMV endotheliitis treated with intravitreal ganciclovir injection

Case report: CMV retinitis following local and systemic immunosuppression

Antiviral therapy for cytomegalovirus retinitis: A systematic review and meta-analysis

Cytomegalovirus anterior uveitis and occlusive retinal vasculitis without retinitis in a patient on immunomodulatory therapy

Continuous High-Dose (6 mg) vs. Low-Dose (3 mg) Intravitreal Ganciclovir for Cytomegalovirus Retinitis After Haploidentical Hematopoietic Stem Cell Transplantation: A Randomized Controlled Study

An Uncommon Concurrence of Cytomegalovirus Retinitis and Corneal Endotheliitis in an Immunocompromised HIV-Negative Patient

Effectiveness of Topical Ganciclovir 2% Monotherapy Versus Combined Steroid Therapy in Cytomegalovirus Endotheliitis

Cytokines pattern after surgical radiofrequency ablation of liver colorectal metastases.

Measuring adolescent care in general practice--successes, problems, and pitfalls.

Severe Occlusive Retinal Vasculitis in an Immunocompetent Patient with Chronic CMV Anterior Uveitis

Prenatal diagnosis of an aberrant right subclavian artery: four vessels arising from the aortic arch?

Topical ganciclovir treatment in patients with cytomegalovirus endotheliitis receiving penetrating keratoplasty